Literature DB >> 6578511

The structure and nucleotide sequence of the 5' end of the human c-myc oncogene.

R Watt, K Nishikura, J Sorrentino, A ar-Rushdi, C M Croce, G Rovera.   

Abstract

We have established the structure and nucleotide sequence of the 5' end of the human c-myc oncogene, using a cloned genomic fragment isolated from a fetal liver library (clone lambda MC41) and cloned cDNA from the human leukemic cell line K562. The human c-myc oncogene consists of three exons and two introns. Primer extension of the human c-myc mRNA of three different cell lines and S1 nuclease protection experiments served to establish the position of two transcription initiation sites. The splicing site of the first exon-intron boundary was determined by comparative analysis of the sequences of the genomic and cDNA clones. The first exon contains termination codons in all three reading frames and no translation initiation signals, confirming our previous observation that the c-myc mRNA has a long 5' noncoding sequence. This first exon also was found to be utilized in the formation of c-myc mRNAs in a variety of human cell lines.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6578511      PMCID: PMC394286          DOI: 10.1073/pnas.80.20.6307

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  Chain length determination of small double- and single-stranded DNA molecules by polyacrylamide gel electrophoresis.

Authors:  T Maniatis; A Jeffrey; H van deSande
Journal:  Biochemistry       Date:  1975-08-26       Impact factor: 3.162

2.  Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose.

Authors:  P S Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

3.  Structure of the glycoprotein gene in rabies virus.

Authors:  A Anilionis; W H Wunner; P J Curtis
Journal:  Nature       Date:  1981-11-19       Impact factor: 49.962

4.  Molecular cloning of the avian myelocytomatosis virus genome and recovery of infectious virus by transfection of chicken cells.

Authors:  B Vennström; C Moscovici; H M Goodman; J M Bishop
Journal:  J Virol       Date:  1981-08       Impact factor: 5.103

5.  Cloning of human mitochondrial DNA in Escherichia coli.

Authors:  J Drouin
Journal:  J Mol Biol       Date:  1980-06-15       Impact factor: 5.469

6.  A catalogue of splice junction sequences.

Authors:  S M Mount
Journal:  Nucleic Acids Res       Date:  1982-01-22       Impact factor: 16.971

7.  Sequencing end-labeled DNA with base-specific chemical cleavages.

Authors:  A M Maxam; W Gilbert
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

8.  Chromosomal location of the genes for human immunoglobulin heavy chains.

Authors:  C M Croce; M Shander; J Martinis; L Cicurel; G G D'Ancona; T W Dolby; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  1979-07       Impact factor: 11.205

9.  Mouse liver and salivary gland alpha-amylase mRNAs differ only in 5' non-translated sequences.

Authors:  O Hagenbüchle; M Tosi; U Schibler; R Bovey; P K Wellauer; R A Young
Journal:  Nature       Date:  1981-02-19       Impact factor: 49.962

10.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

View more
  42 in total

1.  Structural alteration in the MYB protooncogene and deletion within the gene encoding alpha-type protein kinase C in human melanoma cell lines.

Authors:  A J Linnenbach; K Huebner; E P Reddy; M Herlyn; A H Parmiter; P C Nowell; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

2.  A 5'-truncated c-myc gene variant not associated with a risk of cancer.

Authors:  N S Pellegata; G Bergamaschi; D Amadori; A Aloia; P Ballarini; L Del Senno; L Amaducci; G N Ranzani
Journal:  Hum Genet       Date:  1991-09       Impact factor: 4.132

3.  Recurrent anaplastic ependymoma with an abnormal karyotype and c-myc proto-oncogene overexpression.

Authors:  M Debiec-Rychter; J Lasota; J Alwasiak; P P Liberski
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

4.  Physical and functional definition of the Drosophila Notch locus by P element transformation.

Authors:  R G Ramos; B G Grimwade; K A Wharton; T N Scottgale; S Artavanis-Tsakonas
Journal:  Genetics       Date:  1989-10       Impact factor: 4.562

5.  Differential promoter utilization by the c-myc gene in mitogen- and interleukin-2-stimulated human lymphocytes.

Authors:  H E Broome; J C Reed; E P Godillot; R G Hoover
Journal:  Mol Cell Biol       Date:  1987-08       Impact factor: 4.272

6.  Target sequences for cis-acting regulation within the dual promoter of the human c-myc gene.

Authors:  M Lipp; R Schilling; S Wiest; G Laux; G W Bornkamm
Journal:  Mol Cell Biol       Date:  1987-04       Impact factor: 4.272

7.  Accurate and efficient transcription of human c-myc genes injected into Xenopus laevis oocytes.

Authors:  K Nishikura; S Goldflam; G A Vuocolo
Journal:  Mol Cell Biol       Date:  1985-06       Impact factor: 4.272

8.  A single nucleotide change in the c-myc internal ribosome entry segment leads to enhanced binding of a group of protein factors.

Authors:  F E Paulin; S A Chappell; A E Willis
Journal:  Nucleic Acids Res       Date:  1998-07-01       Impact factor: 16.971

9.  Nucleotide sequence 5' of the chicken c-myc coding region: localization of a noncoding exon that is absent from myc transcripts in most avian leukosis virus-induced lymphomas.

Authors:  C K Shih; M Linial; M M Goodenow; W S Hayward
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

10.  Translocation and rearrangement of c-myc into immunoglobulin alpha heavy chain locus in primary cells from acute lymphocytic leukemia.

Authors:  C Peschle; F Mavilio; N M Sposi; A Giampaolo; A Caré; L Bottero; M Bruno; G Mastroberardino; R Gastaldi; M G Testa
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.